ArticleActa pharmacologica Sinica2019

Apatinib, a selective VEGFR2 inhibitor, improves the delivery of chemotherapeutic agents to tumors by normalizing tumor vessels in LoVo colon cancer xenograft mice.

Kai Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.